Purpose To investigate the role of silicone oil as an adjunct to iodine 125 ( 125 I) brachytherapy in attenuating radiation dose and reducing radiation retinopathy. Methods A 16-mm COMS plaque loaded with 125
I) brachytherapy in attenuating radiation dose and reducing radiation retinopathy. Methods A 16-mm COMS plaque loaded with 125 I seeds was simulated in vitro on an eye model containing silicone oil as a vitreous substitute using BrachyDose. The radiation dose ratio of silicone oil vs water to ocular structures was calculated at angles subtended from the centre of the eye. Silicone oil was then used in three choroidal melanoma patients who underwent 23-gauge vitrectomy, silicone oil placement, and 125 
I brachytherapy.
Results Silicone oil reduced the ocular radiation dose in vitro to 65%. Radiation dose ratios on the retina increased from 0.45 to 0.99 when moving from points diametrically opposed to the plaque's central axis. In 10-24 months' follow-up, no patients have developed radiation retinopathy. Each patient required silicone oil removal and experienced cataract progression, and one also developed a retinal detachment. Conclusions This study confirms that silicone oil attenuates radiation dose in vitro, and may protect against radiation retinopathy clinically in patients, however it requires extensive surgical interventions. Further studies in only very selected populations using silicone oil as an adjunct to 125 
Introduction
Although present brachytherapy is very effective in treating uveal melanoma, it has a marked pejorative effect on vision, especially for tumours near the fovea or optic nerve. 1 Techniques to preserve vision are needed. Though endoresection has been used, this technique involves disrupting the retina, which provides a natural barrier to extension of the tumour. 2 Recent preclinical studies suggest using intraocular silicone oil prior to iodine 125 ( 125 I) brachytherapy for uveal melanoma attenuates the radiation dose to vital ocular structures, potentially reducing the development of radiation maculopathy and papillopathy. 3 The authors report their own preclinical study results followed by clinical use of silicone oil as an adjunct to 125 I brachytherapy in three patients with choroidal melanoma. Silicone oil was then used in three cases of posteriorly located medium or large choroidal melanomas, in which each patient underwent microincision vitrectomy, endolaser, 1000-centistoke silicone oil placement, and 125 I plaque with 80-85 Gy. Following determination of proper placement using either diaphanoscopy or indirect ophthalmoscopy, a dummy plaque was sutured in place and ultrasonography was used to determine proper placement. Once it was felt that the plaque would be sutured in proper position, a 23-or 25-gauge vitrectomy was performed. After an air-fluid exchange, the radioactive plaque was then sutured in place and then a silicone-air exchange was performed.
Materials and methods

Case reports
Case 1
A 58-year-old woman presented with a 16 Â 13 Â 9 mm variably pigmented mushroom-shaped choroidal melanoma (T2bN0M0) with borders 0 mm nasal to the disc and 4 mm posterior to the ora in her left eye and vision of 20/40. She underwent 23-gauge vitrectomy, tumour biopsy, endolaser, silicone oil placement, and a 20-mm 125 I plaque. Silicone oil was removed 5 months later, and on 2-year follow-up her tumour has decreased in size without any evidence of radiation retinopathy, but her visual acuity has declined to 2/200 due to a dense cataract.
Case 2
A 69-year-old woman had a 16 Â 13 Â 3 mm posterior multilobed pigmented choroidal melanoma (T2aN0M0) in her right eye with borders 5mm temporal to the fovea and extending to the ora at 9 o'clock, with vision of 20/30. She underwent 23-gauge pars plana vitrectomy with biopsy, endolaser, silicone oil placement, and a 20-mm 125 I plaque. Silicone oil was removed 2 months later, and on 22 months' follow-up her tumour remains regressed without evidence of radiation retinopathy, and most recent visual acuity of 20/40 À 1.
Case 3
A 58-year-old woman had an 11 Â 8 Â 2.5 mm oval pigmented choroidal melanoma (T2aN0M0) along the inferior arcade in her right eye that was 1.5 mm inferotemporal to the disc and 0.7 mm from the fovea with associated subretinal fluid. She underwent 23-gauge vitrectomy with biopsy, endolaser, silicone oil placement, and 16 mm 125 I plaque placement. After 7 months, she was evaluated for silicone oil removal and cataract surgery, and was found to have an inferior rhegmatogenous retinal detachment with significant anterior vitreous contraction, requiring scleral buckle, vitrectomy, and endolaser. On 10 months' follow-up she is 20/200 þ 2 with tumour base regression and no radiation retinopathy.
Discussion
To date, none of our three patients have developed radiation retinopathy. Radiation retinopathy typically occurs 18 to 24 months after brachytherapy, 5, 6 suggesting a potential protective effect of silicone oil in at least the two cases with longer follow-up. Nevertheless, each of these patients required additional operation for silicone oil removal, experienced cataract progression within, and one patient also developed a retinal detachment.
This study confirms that silicone oil attenuates radiation dose in vitro, and may protect against radiation retinopathy clinically in patients. However, we are concerned about the extensive surgery involved and would recommend limiting its use to only very special cases such as posterior pole melanomas in functionally monocular patients. It is critical to consider the risks of silicone oil use in these cases, including multiple surgeries and cataract progression. To our knowledge, there is no previous clinical data in the literature supporting silicone oil decreasing radiation retinopathy. Further studies are needed to elucidate the precise role of silicone oil as an adjunct to 125 I brachytherapy in shielding radiation retinopathy.
Summary
What was known before K Silicone oil may attenuate radiation in vitro.
What this study adds K Confirms silicone oil attenuates radiation dose in vitro. K Shows for the first time that silicone oil attenuates radition retinopathy clinically, but this comes with extensive additional surgery.
